Current Bids
Supply Chain Management
Sourcing & Contract Management
Request for Qualification
Bid Number #: 1512181557
RFx Name: Bastrop - Comparative Medicine and Research Building (CMRB) Expansion
RFx Information:
Open: Dec 29, 2015 3:00 PM
Close: Feb 4, 2016 2:00 PM
Contact Information:
Name: John S Wroth
Email: jswroth@mdanderson.org
Phone: 713-792-8550
The University of Texas MD Anderson Cancer Center
Bastrop - Comparative Medicine and Research Building (CMRB) Expansion - 1512181557
Introduction to MD Anderson
MD Anderson is known throughout the world for high-quality cancer care, research, academic programs and prevention services. Since its establishment in 1941, MD Anderson has made major contributions to improve the outlook for cancer patients everywhere.
MD Anderson was one of the first three federally designated comprehensive cancer centers by the National Cancer Act of 1971. A survey of health professionals has routinely ranked MD Anderson as one of the two premier cancer centers in the nation for the past eight years. Over 55,000 persons annually seek care at MD Anderson. The team approach to cancer care, pioneered at MD Anderson, has been strengthened by consolidating specialty clinics into multi-disciplinary care centers that allow patients to receive more ambulatory care and treatment in a single location.
MD Anderson offers one of the largest bone marrow and stem cell transplantation programs, as well as clinical trials to improve existing therapies. Teams of clinical specialists collaborate with scientists on problems of common interest and test theories that shorten the application of better treatment methods. Translational research studies are responsible for the promising field of chemoprevention, which uses synthetic vitamins to reverse pre-malignant lesions and halt the recurrence of some cancers, and for innovative gene therapy strategies being evaluated for several forms ofcancer.
With faculty and staff working in more than 30 buildings in the greater Houston area and in central Texas, MD Anderson is the largest freestanding cancer center in the world. The physical plant covers more than 11 million square feet, featuring the latest equipment and facilities to support growing needs in outpatient and inpatient care, research, prevention and education. It includes inpatient hospital facilities with 571 beds.
Construction projects include the addition of 12 floors that can accommodate more than 300 new inpatient beds in Alkek Hospital on the North Campus; two new research buildings on the South Campus that will house the Center for Advanced Biomedical Imaging Research and Center for Targeted Therapy as part of the McCombs Institute; and MD Anderson's first facility on its Mid Campus, a 25-story building to support current office space and future growth needs.
In addition to its main campus in the Texas Medical Center and two research campuses in Bastrop County, Texas, MD Anderson has developed a number of local, national and international affiliations
RFx Overview
A non-mandatory pre-submittal conference will be held at 2:00 pm, 1/12/2016, at the MD Anderson Cancer Center Michael E. Keeling Center for Comparative Medicine and Research, 650 Cool Water Drive, Bastrop, TX 78602. AND AT the MD Anderson Cancer Center 1MC Building, 7007 Bertner Avenue, Conference Room 1MC 2.2462, Houston, TX 77030. Owner seeks to engage a Project Architect, and anticipates engaging a construction manager-at-risk, to develop and complete a facility program document that will confirm the parameters and scope of the project. Key outcomes of this effort are expected to include: Completion of a space program that ensures the CMRB is appropriately expanded to meet the needs of the programs that are currently housed in the Main Building.. Development of a detailed project phasing plan, demonstrating an understanding that daily operations cannot be unreasonably interrupted due to modifications to existing building support systems. Design response to owner provided narrative (not yet available) detailing current program needs and projected program needs. Confirmation of the scope of the expansion needed to facilitate the vacating of the Main Building. Identification of, and means for addressing, key constructability issues that could adversely impact the project. Development of a detailed construction cost estimate.
Questions related to this RFP must be sent via the information request form. All questions must be received no later than January 21, 2016 4:00 PM. Questions received after this time will not be accepted. Questions will not be answered via telephone. All answers to any questions or inquiries will be posted on the webpage for all Suppliers to access. It is the intent of MD Anderson to respond to all questions and concerns; however, MD Anderson shall reserve the right to decline to respond to any question or concern.
It is important to note that the supplier or suppliers selected to develop MD Anderson's RFP are not automatically qualified to engage with the Institution for purposes of implementing the recommended strategy or solutions. The engagement of contracted services for implementation can, at MD Anderson's discretion, be solicited via a second and separate Request for Proposal.
Standard Riders and Agreements
1 - Request for Qualification.pdf
2 - Attachment A - Draft Agreeemnt.pdf
3 - Attachment B - Rider 104B.pdf
4 - Attachment C - RFI Template.pdf
5 - HUB Tip Sheet Bastrop CMRB Expansion.pdf
Addendum 1 - Pre-Solicitation Sign-In Sheets.pdf
Addendum 2 - RFI Questions and Answers.pdf
***Interested suppliers should also note that Subcontracting Opportunities are
probable in connection with this solicitation. Please review the HUB Subcontracting Tip Sheet
***RFx refers to RFP, RFQ, RFI, ITB, etc.